Meet Samuel – Your Personal Investing Prophet
- Start a conversation with TipRanks’ trusted, data-backed investment intelligence
- Ask Samuel about stocks, your portfolio, or the market and get instant, personalized insights in seconds
Haleon PLC ( (GB:HLN) ) has shared an announcement.
Haleon plc, the consumer health group behind brands such as Sensodyne, Panadol and Advil, operates globally across oral care, pain relief, vitamins and other everyday health categories, targeting mass-market demand for over-the-counter products. The company leverages its scientific heritage and broad brand portfolio to defend share in key consumer health segments worldwide.
Haleon has published its preliminary full-year 2025 results and proposed a total dividend of 7.1p per share, equivalent to about 38% of adjusted earnings, underscoring strong free cash flow and organic operating profit growth. The board signalled confidence in future performance by indicating it expects to grow the ordinary dividend at least in line with adjusted earnings, a move likely to reassure income-focused investors ahead of a detailed analyst presentation and Q&A on the results.
The most recent analyst rating on (GB:HLN) stock is a Buy with a £4.20 price target. To see the full list of analyst forecasts on Haleon PLC stock, see the GB:HLN Stock Forecast page.
Spark’s Take on GB:HLN Stock
According to Spark, TipRanks’ AI Analyst, GB:HLN is a Outperform.
Haleon PLC’s overall stock score reflects strong financial performance and positive corporate events, which are the most significant factors. Technical analysis and valuation present a more mixed outlook, with some short-term challenges. The earnings call highlights regional strengths but also points to challenges in North America. Overall, the company is well-positioned for future growth, but careful management of liabilities and strategic initiatives will be crucial.
To see Spark’s full report on GB:HLN stock, click here.
More about Haleon PLC
Haleon plc is a global consumer health company listed in London and New York, focused on over-the-counter products across six categories including oral health, vitamins, minerals and supplements, pain relief, respiratory and digestive health, and therapeutic skin care. Its portfolio includes well-known brands such as Advil, Centrum, Panadol, Sensodyne, Theraflu and Voltaren, which are positioned on trusted science and large-scale everyday health demand.
Average Trading Volume: 14,853,124
Technical Sentiment Signal: Buy
Current Market Cap: £36.13B
See more insights into HLN stock on TipRanks’ Stock Analysis page.